Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.8 AUD | -0.34% | -1.58% | -1.67% |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
Feb. 29 | Knight Therapeutics Announces Launch of Minjuvi in Brazil | MT |
Sales 2024 * | 993M 646M | Sales 2025 * | 1.05B 681M | Capitalization | 1.66B 1.08B |
---|---|---|---|---|---|
Net income 2024 * | 101M 65.74M | Net income 2025 * | 118M 76.81M | EV / Sales 2024 * | 2.04 x |
Net Debt 2024 * | 368M 239M | Net Debt 2025 * | 327M 213M | EV / Sales 2025 * | 1.9 x |
P/E ratio 2024 * |
16.6
x | P/E ratio 2025 * |
14.1
x | Employees | 1,996 |
Yield 2024 * |
3.55% | Yield 2025 * |
4.12% | Free-Float | 95.34% |
Latest transcript on GUD Holdings Limited
1 day | -0.34% | ||
1 week | -1.58% | ||
Current month | +0.85% | ||
1 month | +4.61% | ||
3 months | -2.56% | ||
6 months | -0.42% | ||
Current year | -1.67% |
Managers | Title | Age | Since |
---|---|---|---|
Graeme Whickman
CEO | Chief Executive Officer | - | 18-09-30 |
Director of Finance/CFO | - | 11-12-31 | |
Anne Mustow
IRC | Investor Relations Contact | - | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Pollaers
BRD | Director/Board Member | 62 | 21-06-22 |
Graeme Billings
CHM | Chairman | 68 | 11-12-19 |
David Robinson
BRD | Director/Board Member | 75 | 11-12-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 735 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - | |
0.00% | 7 M€ | +4.29% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 11.8 | -0.34% | 161,936 |
24-03-27 | 11.84 | -0.42% | 204,520 |
24-03-26 | 11.89 | 0.00% | 159,374 |
24-03-25 | 11.89 | +1.62% | 159,536 |
24-03-22 | 11.7 | -2.42% | 325,713 |
Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.67% | 1.08B | |
+35.54% | 56.31B | |
-11.22% | 21.72B | |
+14.42% | 18.82B | |
+10.34% | 17.58B | |
-5.75% | 15.64B | |
+14.87% | 14.96B | |
-13.03% | 14.45B | |
+30.74% | 12.04B | |
+26.11% | 10.97B |